First Mercantile Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

First Mercantile Trust’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,947	Closed	-$286K	–	1081
2014 Q4	$286K	Sell	2,947 -8,975	-75%	-$832K	0.02%	625
2014 Q3	$931K	Sell	11,922 -1,227	-9%	-$79.1K	0.08%	350
2014 Q2	$830K	Buy	13,149 +1,585	+14%	+$94.2K	0.07%	398
2014 Q1	$776K	Sell	11,564 -1,250	-10%	-$96.8K	0.06%	461
2013 Q4	$824K	Sell	12,814 -4,700	-27%	-$280K	0.06%	429
2013 Q3	$1.12M	Buy	17,514 +2,500	+17%	+$125K	0.09%	328
2013 Q2	$466K	Buy	+15,014	New	+$400K	0.04%	564

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Mercantile Trust's ALNY Position: Q1 2015 in Review

First Mercantile Trust sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2015, closing a stake of 2,947 shares — an estimated $286K sold.

First Mercantile Trust first reported a position in ALNY in Q2 2013 and held it in 7 quarters. The position peaked at $1.12M in Q3 2013. 238 funds tracked by Wall St. Rank hold ALNY as of Q1 2015.

First Mercantile Trust reported no remaining Alnylam Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
First Mercantile Trust sold 2,947 Alnylam Pharmaceuticals shares in Q1 2015, an estimated $286K.
First Mercantile Trust first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 7 quarters.
First Mercantile Trust's Alnylam Pharmaceuticals position peaked at $1.12M in Q3 2013.
238 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2015.

Based on First Mercantile Trust's 13F filing for Q1 2015, filed 17 Apr 2015.